A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly
Clinical trial NCT04837040 · TERMINATED
Trial details
- NCT number
- NCT04837040
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2023-07-10
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.